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A rapid and sensitive method for the confirmatory analysis of 8 synthetic corticosteroids 
(betamethasone, dexamethasone, prednisolone, 6 methyl prednisolone, triamcinolone, flumethasone, 
beclomethasone, fluocinolone acetonide) is proposed. The method is useful for detecting illegal 
treatments in different animal species. It consists of an extraction and clean-up using the Quick Easy 
Cheap Effective Rugged Safe (QuEChERS) strategy. Quantitative determination is achieved by ultra-
high performance liquid chromatography coupled to high-resolution mass spectrometry with heated 
electrospray ionization in negative mode. Quantification is performed using surrogate matrix matched 
standard calibration curve with dexamethasone-D4 as the internal standard. The method was validated 
for analyzing liver samples according to the criteria established by Decision 2002/657/EC. Linearity 
was assessed in the 1-10 μg kg-1 range and linear correlation coefficients were over 0.99 for all the 
analytes. CCα ranged from 0.04 to 0.16 μg kg-1 for substances without maximum residue limit. The 
method allows confident quantification and confirmation of corticosteroids in liver samples, and its 
simplicity makes it suitable for analyzing large numbers of samples. 
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Natural corticosteroids are a family of steroidal hormones derived from cholesterol and produced in 
the external portion of the adrenal cortex. These compounds have anti-inflammatory properties with 
analgesic and antipyretic effects. Pharmacological doses are used for their palliative anti-inflammatory 
or immunosuppressant effects [1]. Large numbers of synthetic steroids with these specific 
characteristics are produced [2, 3]. Some of these corticosteroids are used for therapeutic purposes in 
human or veterinary medicine. For instance, dexamethasone (DEX) is twenty times more powerful 
than cortisol and has a longer period of action [4], and it is used in human and veterinary medicine.  
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In veterinary practice, when used in low doses for long periods of time corticosteroids are considered 
to be growth promoters, since they act on lipid metabolism [1,5]. The association between 
corticosteroids and other growth promoters give them synergic effect and depletes the urinary 
concentration of molecules administered for illicit purposes [6-8]. Moreover, corticosteroids 
negatively affect the organoleptic properties of meat and cause adverse effect on human health [9].  
In the European Union, corticosteroids are strictly regulated and classified in Group B2f, as “Other 
substances that exert a pharmacological activity” [10]. European Regulation 37/2010 [11] only sets 
maximum residue limits (MRL) in liver matrix for betamethasone (BET) (2 µg kg-1 in bovine and pig), 
DEX (2 µg kg-1 in ovine and pig), prednisolone (PLN) (10 µg kg-1 in bovine) and 6-
methylprednisolone (MPLN) (10 µg kg-1 in bovine). However, these corticosteroids may only be used 
for therapeutic purpose, with regular prescription by the veterinary [12]. To detect the use of 
prohibited substances or improper administration of regulated ones, and with the ultimate aim of 
protecting consumer health from unwary intake of residues, the European authorities have established 
national residue control plans [10]. These plans require analytical methods with high sensitivity, 
specificity and accuracy. 
In food testing laboratories, veterinary drug residues are normally analyzed using liquid 
chromatography (LC) coupled to mass spectrometry (MS), mainly using triple quadrupole (QqQ) 
instruments. However, the resolution of QqQ instruments is not always sufficient for resolving 
coeluting isobaric interferences in complex matrices, thus affecting the reliability of the results [13-
15]. In this sense, it is advantageous to use high-resolution mass spectrometry (HRMS) to analyze this 
type of compounds [15-17]. HRMS is a powerful tool because of its resolving power and mass 
accuracy, which allow to discriminate between interference and target ions, thus providing high 
sensitivity for analyzing low concentrations of analytes [18].  
LC/HRMS has greatly improved laboratories’ ability to characterize and confirm detected substances, 
and official control laboratories are increasingly using HRMS to detect and confirm food 
contaminants. 
Moreover, control laboratories need high throughput analysis methods. In this sense, sample treatment 
is the bottleneck for analyzing corticosteroids in food samples. Regarding the extraction of 
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corticosteroids, relatively polar solvents, such as ethyl acetate, acetonitrile, methanol or hydro-organic 
mixtures have been proposed, in most cases using conventional shaking, or ultrasonic bath. Extracts 
are further cleaned up, mostly by solid phase extraction (SPE), especially in the reverse mode. Thus, 
some authors describe the use of C18 [17, 19] or polymeric cartridges [20,21], and less frequently the 
combination of two SPE steps, with C18 and SiO2 cartridges [22], or the use of mixed mode strong 
cation exchange cartridges [23]. 
The QuEChERS methodology [24] allows to markedly speed up the sample treatment and is a very 
attractive approach for control laboratories dealing with large numbers of samples. Recent reports 
describe a QuEChERS based method for analyzing flumethasone (FLU) in beef muscle [25], and 
multifamily residue methods that include some corticosteroids [16]. 
The aim of this work is to develop a high throughput and sensitive method for simultaneously 
determining 8 synthetic corticoids in liver samples, namely DEX, BET, PLN, MPLN, FLU, 
triamcinolone (TRI), beclomethasone (BCL) and fluocinolone acetonide (FCN). The QuEChERS 
strategy is applied for the extraction and clean up steps, and the quantitative determination is 
performed by ultra-high performance liquid chromatography (UHPLC) coupled to high-resolution 
mass spectrometry, using a hybrid quadrupole Orbitrap mass spectrometer, with heated electrospray 
ionization (HESI). 
 
Materials and Methods 
 
Chemicals and Reagents 
 
BCL, BET, DEX, FLU, FCN, MPLN, PLN and TRI with a minimum purity of 95% each, were 
purchased from Sigma-Aldrich (Seelze, Germany); Dexamethasone-D4 (DEX D4) 95%, was purchased 
from CDN Isotopes Inc. (Canada). 
Purified Water Type I was obtained from a Milli-Q System (Millipore, Billerica, MA, USA); methanol 
HPLC was obtained from Fisher Scientific (UK); acetonitrile HPLC hypergrade (ACN) was obtained 
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from LiChrosolv (Darmstadt, Germany); formic acid and anhydrous sodium acetate were obtained 
from Sigma-Aldrich (Seelze, Germany); chloroform, hexane, sodium hydroxide and glacial acetic acid 
99% were obtained from Panreac (Barcelona, Spain); QuEChERS salts (6 g of magnesium sulfate and 
1.5 g of sodium acetate) and dispersive tubes (0.4 g of Primary Secondary Amines (PSA), 0.4 g of C18 
and 1.2 g of magnesium sulfate) were obtained from Agilent Technologies (New Castle, DE, USA). 
All other chemicals were analytical reagent grade. 
Individual stock solutions (1000 mg L-1) of BCL, BET, DEX, FLU and TRI, were prepared by 
weighing 25 mg separately, and dissolving it into 25 mL of methanol in dark volumetric flasks. 
Individual stock solutions (1000 mg L-1) of FCN, MPLN and PLN were prepared by weighing 25 mg 
separately and dissolving it into 25 mL of ACN:chloroform (50:50) mixture in dark volumetric flasks. 
These solutions were stable at least for 2 years at -20±3°C. Intermediate solutions (20 mg L-1) were 
prepared by taking 0.5 mL of each stock solution with automatic pipette, bringing it to a 25 mL dark 
volumetric flask and wiping with ACN. These solutions were stable at least for 1 year at -20±3°C. 
Working solutions (0.4 mg L-1) were prepared by taking 0.5 mL of 20 mg L-1 solution and diluting to 
25 mL with mobile phase. These solutions were stable for 3 months at + 4±1°C. 
Internal standard (DEX-D4) stock solution (1000 mg L-1) was prepared by weighing 10 mg of 
commercial standard and dissolving it in a dark flask with 10 mL of methanol. This solution was 
stable at least for 2 years at -20±3°C. Internal standard intermediate solution (20 mg L-1) was prepared 
by taking 0.5 mL of DEX-D4 1000 mg L-1 solution and diluting to 25 mL with ACN. This solution was 
stable for 1 year at -20±3°C. Internal standard working solution (0.4 mg L-1) was prepared taking 0.5 
mL of intermediate solution of DEX-D4, putting it to a 25 mL volumetric dark flask and mixing with 
re-suspension solution (water:ACN (80:20) mixture). This solution was stable for 3 months at + 
4±1°C. 
Formic acid 0.1% (mobile phase A) was prepared daily by measuring 1 mL of formic acid with an 
automatic pipette and transferring it into a one liter flask with water type I, to obtain 1 liter of solution, 






A Vanquish UHPLC Ultimate 3000 binary pump, with a CORTECS column (Waters) C18 (50 x 2.1) 
mm, 1.6 µm, was used. Oven temperature was +40ºC and flow rate was 400 µL min-1. The mobile 
phases were aqueous 0.1% formic acid (A) and ACN Hypergrade (B), and the gradient program was 
(time min, % B): (0, 20); (6, 30); (6.1, 100); (7, 100); (7.5, 20); (9.0, 20). Total run time was 9 
minutes. 
The chromatographic system was coupled to a hybrid quadrupole-Orbitrap HRMS instrument (Q-
Exactive, Thermo Scientific, Bremen, Germany), with a heated electrospray ionization (HESI) in 
negative ionization mode. The Product Reaction Monitoring (PRM) acquisition mode was applied. In 
the PRM mode the precursor ions are isolated by the quadrupole and fragmented at the high energy 
collisional dissociation (HCD) cell. The product ions are analyzed at the Orbitrap mass analyzer, and 
the traces for the selected quantification and confirmation ions are acquired, using time windows, with 
high resolution.  
The following conditions were used: heater temperature 310°C, capillary temperature 350°C, sheat 
flow gas (N2) 40 L h-1, auxiliary gas 10 L h-1 and spray voltage 3.5 kV. The mass spectrometer was 
calibrated daily to ensure a mass accuracy better than 5 ppm, using Pierce LTQ Velos ESI Positive ion 
and Pierce LTQ Velos ESI Negative ion calibration solutions (Thermo Fisher Scientific, Rockford, IL, 
USA). The isolation window in the quadrupole was 2 Da. We set a collision energy (NCE) of 10% for 
all compounds, except for FCN (15%), a resolution of 70,000 (m/z 200, FWHM), scanning rate 2 Hz 
and automatic gain control of 5e6 with a maximum injection time of 100 ms. The information about 
precursor, quantification and confirmation ions for each analyte is shown in Table 1. 
To control the UHPLC-HRMS and data processing, TraceFinder 4.1 software (Thermo Fisher 
Scientific, San Jose, CA, USA) was used. 
Nitrogen was obtained from a Zephyr generator (Clantecnologica, Seville, Spain). 
A Retsch GM200 blender (Haan, Germany) was used for sample homogenization. A vertical agitation 
system (AGYTAX SR1 CP57, Spain), a refrigerated centrifuge (Hettich Rotanta 460R, Germany), a 
nitrogen evaporation system with controlled temperature (Turbo-VAP LV, Biotage, Sweden), an 
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ultrasonic bath (Selecta, Barcelona, Spain), a multiple vortex agitator (Genius 3, Germany) were used 
in the extraction steps, Whatman 2 mL vials with 0.45 µm PVDF filter and class A volumetric glass 




Liver samples from various animal species (bovine, porcine, ovine, aviary and rabbit) were stored 
immediately on reception at -20°C in a properly numbered plastic jar until analysis. Liver samples 
were properly homogenized before analysis using a laboratory blender.  
All blank samples used to validate the procedure were analyzed to confirm the absence of 
corticosteroids. 
 
Extraction and clean up procedure 
For extraction, 50 mL tubes to weigh 5g of liver sample were used, and 100 μL of internal standard 
0.4 mgL-1 was added. After shaking for 30 seconds, 10 mL of water type I was added. Then 15 ml of 
ACN was added, and this mixture was shaken in a vortex. QUECHERS salts (6 g MgSO4, 1.5 g 
CH3COONa) were added, and the sample was shaken using vertical shaker, sonicated, and centrifuged 
at 3500 rpm for 5 minutes at + 5°C. One 10 ml aliquot was transferred to a dispersive tube containing 
0.4 g PSA, 0.4 g C18 and 2 g MgSO4, shaken using a multivortex and a vertical shaker, sonicated, and 
centrifuged at 3500 rpm for 5 minutes at + 5°C. The supernatant was evaporated to dryness at +45°C 
for 45 minutes. The dry residue was re-dissolved with 500 µL of re-suspension solution, shaken in 
vortex, sonicated and filtered using vials with an incorporated filter. Finally, 5μL of the extract was 
injected into UHPLC-HRMS system. 
 




Compounds were identified by retention time (RT) and accurate mass. Maximum permitted deviation 
of the retention time was set at 1%, related to the RT of the analytes in surrogate matrix matched 
standards (SMMS) extracts. Ions selected in the quadrupole were the formate adducts for all 
compounds, due to the ability of corticosteroids to form adducts, except for TRI. These ions were 
partially fragmented in the collision cell and afterwards analyzed using HRMS.  
We used as quantification ion a fragment of the molecule in the majority of cases, except for BCL and 
FCN (Table 1): in these cases we used the formate adduct of the molecule. In addition to the 
quantification ion, two confirming ions were monitored (when possible) in the same experiment using 
a mass accuracy better than 5 ppm. Table 1 shows the confirmation ions for each analyte. The ion ratio 
(ratio between the quantification ion and the confirmation ion) was used as an additional criterion for 
confirming positive results. The ion ratio of the compounds in the sample should be in agreement with 
that of the surrogate matrix matched standards (SMMS) with a maximum tolerance of ± 20%. 
 
Calibration 
Calibration was performed using SMMSs in the range 1-10 µg kg-1 and adding Dexamethasone-D4 as 
internal standard according to 657/2002/CE Decision and its interpretation [26, 27]. SMMSs were 
prepared as follows: blank samples were spiked with a mixture of analytes and internal standard, and 
were left during 30 min before carrying out the analytical procedure. The SMMSs were then submitted 
to the complete analytical procedure (i.e. QuEChERS+UHPLC-MS/HRMS). 
The calibration curve for each analyte was obtained by linear regression analysis of the ratio between 
the peak area of the analyte and that of the internal standard plotted against the analyte concentration. 
This type of calibration provides results already corrected for matrix effect and recovery. 
Linearity was assessed by calculating the correlation coefficient (r2) and point-to-point deviation. The 
value of r2 was > 0.999 for all analytes except DEXA, for which r2 was 0.998. Residuals requirements 





Results and Discussion 
 
Optimization of UHPLC/HRMS  
The chromatographic separation was performed at +40ºC with a CORTECS C18 core shell column 
using a mobile phase based on water with 0.1% formic acid and ACN. The chromatographic 
conditions, in terms of gradient and flow rate, are described in section 2.2. Separation of the 8 
compounds was achieved within 6 minutes, and DEX and BET stereoisomers were completely 
resolved (Figure 1). Total chromatographic run time, including re-equilibration, was 9 minutes. 
MS detection is generally based on corticosteroids’ ability for adduct formation. Addition of low 
concentration (0.1%) of acetic or formic acid in the mobile phase induces the formation of acetate or 
formate adducts [18, 28-30]. For HRMS detection with the Q-Orbitrap spectrometer, negative 
ionization and the PRM mode were used; PRM is similar to Product Ion Scan in triple quadrupole 
instruments, but generates a HRMS product ion spectrum.  Thus, in PRM, the precursor ion is selected 
in the quadrupole (isolation window 2 Da), then fragmented in the HCD cell, and the product ions are 
analyzed at the Orbitrap mass analyzer. For all the analytes the formate adduct was selected as 
precursor ion, except for TRI, for which the [M-H]- ion was chosen (Table 1). Fragmentation 
experiments, varying the collision energy, were performed to select suitable quantification and 
confirmation ions. It was observed that formate adducts for BCL and FCN underwent lower 
fragmentation, with [M+HCOO]- ions showing intense signals in the HRMS product ions spectra, and 
thus they were selected as quantification ions. The formate adduct was selected as confirmation ion for 
all analytes except for TRI, BCL and FCN.  Information about quantification and confirmation ions 
for all the analytes is given in Table 1. 
 
Optimization of the extraction method 
Liver samples were used to optimize various parameters of the extraction method.  
The QuEChERS approach was first proposed for the analysis of pesticides in fruits [24], but it is 
currently applied in different fields of analysis [31, 32]. Commercial QuEChERS Kits for fatty 
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samples were assayed. ACN was used as extraction solvent, sodium acetate and magnesium sulphate 
as a salting-out medium and a mixture of PSA and C18 as a dispersive media for clean-up. 
The standard QuEChERS procedure uses 10 g of sample and 15 mL of ACN. During the assays, it 
became necessary to add water to the samples to prevent them from becoming too viscous and to 
allow proper extraction. Thus, in the preliminary tests, the ratio of sample to the amount of water 
added was evaluated, and proportions of 2, 1, 0.5 and 0.3 were tested using samples spiked at 1 µg kg-1 
concentration. The ratio 0.5 gave the extracted sample an appropriate density and an effective 
separation of the mixture, with a clean upper layer after centrifugation, suitable for chromatographic 
analysis. 
In order to avoid matrix overload in the chromatographic system, the sample weight was investigated 
(3, 5 and 10 g). 5 g was enough to detect and confirm concentrations of at least 1 µg kg-1, and thus it 
was not necessary to analyze a larger amount of sample. Therefore, for the extraction step the 
established conditions were: 5 g of sample, 10 mL of water, 15 mL of ACN, and 6 g of magnesium 
sulfate and 1.5 g of sodium acetate. Afterwards, the organic layer was cleaned-up by dispersive solid 
phase extraction with PSA, C18 and magnesium sulfate, the extract was evaporated to dryness, and the 
solid residue dissolved in water:ACN (80:20).Finally, a commercial QuEChERS kit for drug residues 
in meat was also tested.  This kit uses sodium chloride in the extraction step and C18 as the dispersive 
medium for clean up; the results were not successful, since the clean-up step was not effective enough 
and the extracts were too fatty, and thus this kit was discarded.  
The efficiency of the QuEChERS extraction method using the fatty samples kit was evaluated by 
recovery studies. Extraction recoveries were determined using spiked blank porcine liver samples, 
previously analyzed and confirmed to be free of analytes. We followed this approach, that can led to 
some overestimation of recoveries, because there were no certified reference materials available. Thus, 
aliquots of a blank liver sample were fortified at 1, 2 and 10 µg kg-1. For each concentration level, two 
sets of samples (n=6 each) were prepared, the first one spiked before the extraction step and the 
second one spiked after extraction and clean-up, and the results of both sets were compared. The 
procedure was repeated on three different days, for a total of 18 replicates at each concentration level. 
Absolute recoveries ranged from 35 to 49%, with RSD values below 15%. Although absolute 
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recoveries lie in the low range, values were reproducible. In addition, calibration by SMMS corrects 
for extraction recoveries. 
The proposed method is very convenient for routine analysis of corticosteroids in food samples, in 
laboratories with high workload. Compared to methods based on a conventional extraction followed 
by a clean-up by SPE, the new method reduces the time spent in sample treatment in about 50%. 
 
Method validation 
The method was validated according to 657/2002/EC Decision [26], and the results are collected in 
Table 2. The validation study was performed using porcine liver as the basic matrix. 
Blank studies 
The analytical method was tested in blank liver samples from different species (bovine, ovine, swine, 
avian and rabbit) with satisfactory results. No signal in the retention time of the analytes could be 
measured, demonstrating the method’s selectivity. The results were also evaluated in terms of internal 
standard response: RSD% among different species was 7.8%, proving that the matrix effect was very 
limited. These results evidenced that the different liver matrixes were equivalent in terms of the 
method performance. 
Linearity 
The criteria for evaluating linearity are described in calibration section. We found satisfactory results 
for all analytes in the validation range (1-10 µg kg-1), with correlation coefficients > 0.99. Response 
factor as a second linearity criterion was also determined. Response factor was calculated as the ratio 
between the response (peak area) of each calibration point and its theoretical value of concentration. A 
good linearity implies the parameter to be equal for all calibration points. The parameter was evaluated 
in terms of RSD between all calibration points. In all cases was below 20%, demonstrating the good 
linearity of the method. 
Precision  
Precision was determined, in terms of reproducibility, from experiments conducted on three different 
days and extracting 6 spiked samples per day. Samples were spiked at 3 different concentrations, 
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namely 1, 2 and 10 µg kg-1, and were extracted using different reagent batches and by different 
analysts. The method’s precision, expressed as the RSD, ranged from 2.9 to 13.5%. 
Trueness 
Since no certified reference material was available, trueness was calculated in terms of recovery of 
spiked samples. Results were satisfactory, in the 78-101% range, in agreement with 657/2002/EU 
recommendations. Slopes obtained in regression analysis of spiked and calculated concentration data 
were close to 1, with regression coefficients higher than 0.99. 
CCα and CCβ 
On one hand, for compounds with a published MRL (namely DEX, BET, PLN, MPLN in liver of 
some particular species) [11], CCα and CCβ were calculated from blank samples spiked at the MRL 
level, according to the guidelines in Decision 657/2002/CE. On the other hand, for compounds with no 
MRL, these parameters were calculated using the ISO 11843 extrapolation approach [33]. CCα ranged 
from 0.04 to 0.16 μg kg-1, depending on the analyte. CCβ results ranged from 0.08 to 0.35 μg kg-1. 
These values point out that the method is highly sensitive. Results are shown in Table 2.  
 
The laboratory has participated in proficiency tests using the new method and very satisfactory results 
have been achieved; Fapas 02339 Food Chemistry exercise consisted of a bovine liver containing BET 
(5 µg kg-1). Results were excellent, with a Z-score of 0.0, proving the suitability of the proposed 
method.  In the 4th run of Progetto Trieste interlaboratory exercises, the method was applied to the 
analysis of a lyophilized bovine liver sample. DEX was detected and quantified (2.49 µg kg-1), and the 
obtained z-score was 0.41.  
The new method is currently used at the laboratory for the analysis of liver samples from various 
species from different slaughterhouses in Catalonia, as a routine method of analysis. Figure 2 shows 
the chromatogram of a porcine liver sample that contained 1.5 µg kg-1 of  DEX. In addition to the 
DEX peak, some small peaks can be observed at the trace chromatograms of PLN, BCL and FCN, at 
their corresponding retention time windows. However, these peaks are below the limit of 






The new method combines the QuEChERS strategy for sample treatment with the confirmatory 
analysis by UHPLC-MS/HRMS of 8 synthetic corticosteroids. On the one hand the QuEChERS 
approach allows to notably increasing the method throughput, since time for sample treatment is 
reduced by about 50% in comparison with methods using conventional extraction and SPE clean up. 
In addition, there is a remarkable waste reduction.  On the other hand, the use of HRMS provides 
excellent performance in terms of selectivity and also sensitivity, which are critical issues in the 
analysis of low concentration levels in complex samples. The method is very simple and rapid, and up 
to 30 samples can be daily processed at the laboratory by a single operator. These characteristics are 
essential for an effective and reliable food safety control. In addition, they facilitate the market 
withdrawal of non-compliant products, containing illicit synthetic compounds used as growth 
promoters in livestock farming. 
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a:  bovine and porcine liver; b:  ovine and porcine liver; c:  bovine liver 
  
Compound MRL  (µg kg-1) 
Concentration 









MRL No MRL MRL No MRL 
BET 2a 
1 80.1 8.3 
2.3 0.16 2.6 0.27 2 78.5 11.0 
10 87.0 9.4 
DEX 2b 
1 84.6 13.9 
2.4 0.11 2.7 0.21 2 78.4 13.5 
10 85.9 10.0 
MPLN 10c 
1 94.0 4.4 
11.1 0.04 12.2 0.08 2 89.2 4.6 
10 91.9 7.4 
PLN 10c 
1 87.2 7.2 
11.2 0.04 12.4 0.13 2 83.1 9.3 
10 88.9 8.4 
BCL --- 
1 98.6 5.5 
--- 0.15 --- 0.35 2 94.0 2.9 
10 94.5 8.1 
FLU --- 
1 92.6 4.6 
--- 0.06 --- 0.13 2 92.2 4.6 
10 92.6 7.1 
FCN --- 
1 93.1 5.0 
--- 0.10 --- 0.18 2 89.5 6.4 
10 92.0 7.4 
TRI --- 
1 101.2 4.8 
--- 0.05 --- 0.13 2 90.9 6.2 










Fig. 2 LC-MS/HRMS ion chromatograms of a porcine liver sample containing DEX (1.5 µg kg-1) 
